Head circumference was 36.5 cm
(microcephaly), with open flat anterior fontanel, no
old man face, and palpebral conjunctiva was pale
and sclera was anicteric. There was no palpebral
edema. The right pupil was 3 mm and reactive to
light while the left pupil cannot be assessed since it
was covered with whitish discoloration. Abnormal
repetitive, uncontrolled bilateral eye movement from
side to side was noted. There was no nasal flaring
and cyanosis at lips and tongue. No cervical
lymphadenopathy was noted.
He had symmetrical chest expansion, with
intercostal and epigastric retractions, the prominent
appearance of the intercostal area due to thinning of
subcutaneous fat. The respiratory rate was 62 bpm,
regular, coarse rales on both lung fields, with no
wheezing, equal fremitus. Ictus cordis was not
visible and but palpable at IV-V intercostal space on
the left midclavicular line, the thrill was felt. The
heart rate was 160 beats per minute, regular, with
continuous murmur grade 4/6 on the left
infraclavicular area, radiating to the back and the
thrill was palpable.
Abdomen looked globular, soft on palpation,
with normal bowel sound with no palpable liver,
good skin turgor. There was no edema on
extremities, but with muscle hypotrophy and
thinning of subcutaneous fat. The blood pressure
was 70/40 mmHg, peripheral pulses were full and
regular, capillary refill time less than 2 seconds.
There was no abnormality on genitalia and scrotum
examination, both testicles are palpable.
Complete blood count revealed anemia,
leukocytosis, electrolyte imbalance, low serum iron,
normal liver, and kidney function. Blood culture was
drawn, revealed no growth. Chest X-ray revealed
bronchopneumonia and congenital heart disease with
cardiomegaly. Echocardiography revealed secundum
atrial septal defect (ASD) Ø 3.7 mm and PDA Ø 3.9
mm.
The patient was managed with bed rest, oxygen
supplementation, empiric broad-spectrum
antibiotics, antipyretic, diuretic, angiotensin
converting enzyme inhibitor, and nutritional
management according to pediatric nutrition care for
marasmus child.
The admitting diagnosis was congestive heart
failure Ross III due to cyanotic congenital heart
disease (patent ductus arteriosus (PDA) and ASD),
bronchopneumonia, marasmus, anemia, and
congenital rubella syndrome.
Oxygen supplementation 1 lpm was
administered. Antibiotic ampicillin 75 mg/6
hours/IV (25 mg/kg/dose) and gentamycin 15 mg/24
hours/IV (5 mg/kg/day) were started. Paracetamol
40 mg/6 hours (10 mg/kg/dose) per oral was given if
temperature >38°C. Anti-cardiac failure medications
namely furosemide 1x3 mg (1 mg/kgBW/day) and
captopril 2x3.125 mg (1 mg/kgBW/dose) were
continued.
The total caloric requirement was 80-100
kcal/kg/day during the initial phase with a total
calorie of 210 kcal was received, through F75 with
the mineral mix (75 kcal/100 ml) via nasogastric
tube (NGT). The F75 was given in an amount of 35
ml every 3 hours and multivitamins. During the
transitional phase, the total caloric requirement was
100-150 kcal/kg/day, given through oral nutrition
supplement (ONS) with high-calorie infant formula
(100 kcal/100 ml) via NGT-oral. The total volume of
feeding was increased gradually.
Ophthalmology assessment revealed right eye
aphasia and left eye congenital cataract. Subsequent
cataract surgery was suggested when the clinical
condition had been improved. We also planned for a
hearing function test. Unfortunately, the device for
hearing function test was out of order. On growth
and development assessment, we found global
developmental delay.
3 DISCUSSION
In 1941, Norman Gregg, Australian ophthalmologist
has first described a syndrome comprising of
cataracts and congenital heart disease with or
without mental retardation and microcephaly that he
associated with rubella infection in the mothers
during early pregnancy (Mason, 2016). CRS group
classification of clinical signs listed below :
A.
Cataract(s), congenital glaucoma, pigmentary
retinopathy, congenital heart disease (most
commonly peripheral pulmonary artery
stenosis, patent ductus arteriosus or ventricular
septal defects), hearing impairment.
B.
Purpura, splenomegaly, microcephaly,
developmental delay, meningoencephalitis,
radiolucent bone disease, jaundice that begins
within the first 24 hours after birth.
Using these clinical signs, the final
classifications of CRS are as follows: (A) Suspect
CRS: infant less than 12 months of age with at least
one sign from group A; (B) Clinical CRS: infant less
than 12 months of age with at least two signs from
group A; or At least one sign from group A and one
sign from group B without any laboratory
confirmation; (C)
Confirmed CRS: suspect CRS